A portable, electricity-free diagnostic could transform emergency care in ambulances, disaster zones, and remote clinics where lab machines are out of reach.

Qualcomm proved Arm broke its license agreement, but the $2 award leaves Arm's licensing model intact and sets an odd precedent.

GlobalFoundries CEO Tim Breen says the whole industry is in short supply, and Japan's up-to-$21B commitment to two Malta, New York plants shows sovereign capital is now funding US chip capacity.

A three-decade review of meeting science finds the most effective leaders listen more than they speak - and that cutting aimless meetings is the fastest productivity win.

CEO Piotr Babieno explains how stability and trust, not one-off hits, convinced Nintendo to back Onyx: The Dark Grip, the first third-party horror exclusive in over a decade.

Sotheby's is auctioning Copernicus, Galileo, and Newton first editions together for the first time, a rare chance to own the scientific revolution.

A military-backed startup's button-sized device is reshaping at-home hormone testing, and telehealth giants are racing to adopt it.

Spain's top flight places four players in the top ten earners; England's cash-rich league must answer why it has just one.

The actor, who lost big on a NYSE-listed gym chain, is back with a budget longevity club that bundles cold plunges, blood panels, and protein muffins.

The WNBA players union chief says $22.2 billion in weekly prediction-market volume is fueling vitriol and safety threats athletes cannot escape.

Apple's first foldable starts at $1,999, and preorder demand is so strong that orders are slipping into 2027, reshaping the foldable market and your upgrade cycle.

The streaming giant's sudden shake-up is a signal to every media executive: narrative and engagement now outweigh internal stability.